Researchers suggest form of Alzheimer’s is transmissible via bone marrow transplants
The progressive neurodegenerative disease is estimated to affect 24 million people globally
Read Moreby Jen Brogan | Apr 3, 2024 | News | 0
The progressive neurodegenerative disease is estimated to affect 24 million people globally
Read Moreby Jen Brogan | Mar 25, 2024 | News | 0
Estimated to affect 2.5 million people in the US, synucleinopathies comprise four neurodegenerative disorders
Read Moreby Jen Brogan | Dec 14, 2023 | News | 0
The collaboration aims to develop biomarker-based diagnostics for the condition
Read Moreby Jen Brogan | Dec 14, 2023 | News | 0
The free programme will be offered to those who are affected by the condition
Read Moreby Jen Brogan | Nov 24, 2023 | News | 0
The findings could benefit patients living with neurodegenerative conditions
Read Moreby Jen Brogan | Nov 22, 2023 | News | 0
The trial will use an AI screening platform to identify those most at risk of dementia
Read Moreby Jen Brogan | Nov 21, 2023 | News | 0
Cerebral SVD contributes to 45% of dementia cases and 20% of ischaemic strokes
Read Moreby Jen Brogan | Nov 20, 2023 | News | 0
The centre will help discover new treatments to prevent, halt and cure the condition
Read Moreby Jen Brogan | Nov 16, 2023 | News | 0
The funding will be used to develop new diagnostic tests, treatments and devices
Read Moreby Jen Brogan | Oct 20, 2023 | News | 0
The new technology was safely trialled on 20 healthy volunteers for the first time ever
Read Moreby Jen Brogan | Sep 21, 2023 | News | 0
The report outlines ways the government can help patients with Parkinson’s disease
Read Moreby Jen Brogan | Aug 10, 2023 | News | 0
The therapy reaches and activates areas of the brain that are central to cognitive enhancement
Read MorePharmaTimes Media Ltd.
Mansard House
Church Road
Little Bookham
Leatherhead
Surrey KT23 3JG
E: editorial@pharmatimes.com
E: subscriptions@pharmatimes.com
T: +44 (0)20 7240 6999
F: +44 (0)20 7240 4479